Skip to Main Content

Paper Details

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
J Clin Invest
29
2022
Author NameAffiliation
Annette M MolinaroUniversity of California san francisco
Annette M MolinaroUniversity of California san francisco
Annette M MolinaroHelen Diller Family Comprehensive Cancer Center
Joanna J PhillipsUniversity of California san francisco
Joanna J PhillipsUniversity of California san francisco
Joanna J PhillipsHelen Diller Family Comprehensive Cancer Center
Joanna J PhillipsUniversity of California san francisco
Joanna J PhillipsHelen Diller Family Comprehensive Cancer Center
Joanna J PhillipsUniversity of California san francisco
Nicholas ButowskiUniversity of California san francisco
Nicholas ButowskiHelen Diller Family Comprehensive Cancer Center
Nicholas ButowskiUniversity of California san francisco
Nicholas ButowskiHelen Diller Family Comprehensive Cancer Center
Nancy Ann Oberheim BushUniversity of California san francisco
Nancy Ann Oberheim BushHelen Diller Family Comprehensive Cancer Center
Nancy Ann Oberheim Bush
Nancy Ann Oberheim BushUniversity of California san francisco
Nancy Ann Oberheim Bush
Nancy Ann Oberheim BushHelen Diller Family Comprehensive Cancer Center
Mitchel S BergerUniversity of California san francisco
Mitchel S BergerHelen Diller Family Comprehensive Cancer Center
Mitchel S BergerUniversity of California san francisco
Mitchel S BergerHelen Diller Family Comprehensive Cancer Center
Hideho OkadaUniversity of California san francisco
Hideho OkadaHelen Diller Family Comprehensive Cancer Center
Hideho OkadaParker Institute for Cancer Immunotherapy
  • 1 - 26

Datasets